Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

India vows to press tobacco companies for bigger health warnings

A shopkeeper takes out a cigarette from a box for a customer in Kolkata October 15, 2014. Reuters/Rupak De Chowdhuri/Files (Reuters) – India is committed to boosting the size of health warnings on tobacco products, the government said on Friday, seeking to deflect criticism for delaying tougher new packaging rules beyond a deadline of April […]

Read More »

Aerie Pharma shares battered as eye drug fails study

<span class="articleLocation”>(Reuters) – Aerie Pharmaceuticals Inc lost nearly three-quarters of its value after the company said its lead experimental eye drug failed a late-stage study. The eye drop, Rhopressa, did not lower pressure inside the eye as much as timolol, a commonly prescribed drug, the company said. Increased pressure in the eye is often a […]

Read More »

FreshBlood in the healthcare marketing world

Med Ad News had a conversation recently with Robert Finkel, former Kane and Finkel principal who opted to shutter his agency last year, about his new company, FreshBlood Health Market Consultants. Finkel outlined his new business model and what work he has been doing with clients. RF: It’s been about a year since I wound […]

Read More »

Study Uncovers Healthcare Industry Trust and Knowledge Deficit Among Female Consumers

Women Are Healthcare Decision-Makers for Themselves and Others but Are Not Confident They Are Making Good Decisions NEW YORK, NY–(Marketwired – April 23, 2015) – Although women make the vast majority of healthcare decisions for themselves and others, 63 percent of women in the U.S., U.K., Germany, Japan, and Brazil lack confidence in the healthcare […]

Read More »

Publicis Touchpoint Solutions Announces Two New Executive Appointments

Tom Clark and Archie Robinson move into new leadership roles at Touchpoint Yardley, PA—April 21, 2015—Publicis Touchpoint Solutions, Inc—a leading provider of customized, omni-channel healthcare sales, service, and clinical teams—announced two executive appointments today. Tom Clark has been promoted into the role of executive vice president of business development, having formerly served as vice president of […]

Read More »

Palio Creative Leader Passes Torch To Distinguished Leadership Team

NEW YORK, NY – April 20, 2015 – PALIO, an inVentiv Health advertising agency that ignitesbold and beautifully disruptive ideas, announced today that Chief Creative Global Officer GuyMastrion has departed the agency. President Kim Johnson and Mastrion have worked over thepast year to chart the next phase of the agency’s evolution, including strengthening the executiveteam […]

Read More »

PARTNERS+simons President & CEO Named CEO of Myelin Health

BOSTON–(BUSINESS WIRE)–PARTNERS+simons, a 25-year old brand communications and integrated marketing services firm specializing in the healthcare and financial services industries, announced today that President and CEO Rich Levy has added responsibilities as the new CEO of Myelin Health. Rich will operate both as CEO of Myelin Health and president & CEO of PARTNERS+simons. Myelin Health, […]

Read More »

GlaxoSmithKline Recalls Flu Vaccine Over Potency Issues

U.K.-based GlaxoSmithKline (GSK) announced on April 14, 2015 that it was recalling all remaining lots of its 2014-2015 Flulaval Quadrivalent flu vaccine. The company noted that two of the components of the vaccine, the B strains, appeared to have lost potency below the minimum specifications. The potency issue, according to the company, the U.S. Centers […]

Read More »

Restrictive Drug Plan Regulations Will Hurt Patients

DALLAS, April 20, 2015 /PRNewswire-USNewswire/ — Increasing unnecessary regulations on drug plans could inflict higher costs on the 220 million Americans who get their medications through a managed drug plan, according to a  new report by National Center for Policy Analysis Senior Fellow Devon Herrick. “The degree to which drug benefit plans are managed efficiently […]

Read More »

Lupin Launches Zaxine in Canada

MUMBAI and MONTREAL, April 20, 2015 /PRNewswire/ — Zaxine 550mg (rifaximin) is a long term antibiotic treatment for adults living with hepatic encephalopathy (HE), a complication of liver disease (cirrhosis). HE can lead to a wide spectrum of mental and physical symptoms, including confusion, disruption in sleep patterns, personality changes and coma Zaxine® 550mg has approved by […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom